AGIO Stock Summary and Trading Ideas (Agios Pharmaceuticals | NASDAQ:AGIO)

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Agios Pharmaceuticals trades on the NASDAQ stock market under the symbol AGIO.

As of April 17, 2025, AGIO stock price climbed to $27.66 with 552,909 million shares trading.

AGIO has a beta of 1.74, meaning it tends to be more sensitive to market movements. AGIO has a correlation of 0.17 to the broad based SPY ETF.

AGIO has a market cap of $1.58 billion. This is considered a Small Cap stock.

Last quarter Agios Pharmaceuticals reported $11 million in Revenue and -$1.94 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.31.

In the last 3 years, AGIO traded as high as $62.58 and as low as $16.75.

The top ETF exchange traded funds that AGIO belongs to (by Net Assets): VTI, VB, IWM, XBI, VXF.

AGIO has underperformed the market in the last year with a return of -4.0%, while the SPY ETF gained +6.0%. In the last 3 month period, AGIO fell short of the market, returning -13.1%, while SPY returned -10.7%. However, in the most recent 2 weeks AGIO has outperformed the stock market by returning -2.7%, while SPY returned -6.8%.

AGIO support price is $25.94 and resistance is $28.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGIO shares will trade within this expected range on the day.